Identification of a new diagnostic antigen for glanders using immunoproteome analysis

Sudhir K Dohre1, Aayushi Kamthan1, Sandeep Singh1

  • 1Microbiology Division, Defence Research & Development Establishment, Gwalior, 474002, Madhya Pradesh, India.

Insights

Researchers identified GroEL as a potential diagnostic tool for glanders, a serious equine disease. This discovery could lead to faster and more accurate detection of Burkholderia mallei infections in horses.

Area of Science:

  • Veterinary Microbiology
  • Immunology
  • Proteomics

Background:

  • Glanders is a highly contagious and zoonotic disease affecting equids, caused by the bacterium Burkholderia mallei.
  • Burkholderia mallei is classified as a Biosafety Level 3 pathogen and a significant biothreat agent, necessitating robust diagnostic strategies.
  • Current diagnostic methods for glanders can be time-consuming, highlighting the need for simple and rapid tools for disease control and surveillance.

Purpose of the Study:

  • To identify potential protein antigens of Burkholderia mallei for the development of a diagnostic test for glanders.
  • To evaluate the diagnostic potential of identified antigens, specifically GroEL, in serological assays for glanders.

Main Methods:

  • Proteomic analysis and 2D immunoblotting using equine sera were employed to identify immunoreactive protein antigens of Burkholderia mallei.
  • The gene encoding the identified GroEL protein was cloned and expressed in E. coli, followed by purification using Ni-NTA affinity chromatography.
  • Recombinant GroEL protein was utilized in an Enzyme-Linked Immunosorbent Assay (ELISA) to test a panel of known glanders-positive and negative equine serum samples.

Main Results:

  • Twelve potential protein antigens of Burkholderia mallei with diagnostic potential were identified through proteomic and immunoblotting techniques.
  • Key immunoreactive proteins identified include GroEL, translation elongation factor Tu, elongation factor Ts, arginine deiminase, malate dehydrogenase, and DNA-directed RNA polymerase subunit alpha.
  • The developed ELISA using recombinant GroEL demonstrated high diagnostic accuracy, with a sensitivity of 96% and a specificity of 98.7% when tested against equine sera.

Conclusions:

  • The study successfully identified GroEL as a promising candidate antigen for the serodiagnosis of glanders.
  • The recombinant GroEL-based ELISA shows significant potential for a sensitive and specific diagnostic tool for glanders, aiding in disease control efforts.
  • Further validation and implementation of this GroEL-based diagnostic assay could greatly improve the management and eradication of glanders in equine populations.

Related Concept Videos